Top 10 pipeline blowups, setbacks and snafus in H1 2016
Some years you have to stretch a bit to find a lineup of 10 notable setbacks in the pipeline. In the first half of this year, I could have done one in each quarter and had a few left over for the dishonorable mention column.
What we have here is a collection of gruesome self-inflicted wounds, more evidence that the home run swing looks good on paper and terrible in execution and a new category: the drug that posted positive data but looked bad compared to the competition.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.